These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22950641)

  • 21. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects.
    Marcaccini AM; Meschiari CA; Sorgi CA; Saraiva MC; de Souza AM; Faccioli LH; Tanus-Santos JE; Novaes AB; Gerlach RF
    J Periodontol; 2009 Apr; 80(4):594-602. PubMed ID: 19335079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
    Kaysen GA; Levin NW; Mitch WE; Chapman AL; Kubala L; Eiserich JP
    Blood Purif; 2006; 24(5-6):508-16. PubMed ID: 17077623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Main determinants of PON1 activity in hemodialysis patients.
    Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
    Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients.
    Bargnoux AS; Cristol JP; Jaussent I; Chalabi L; Bories P; Dion JJ; Henri P; Delage M; Dupuy AM; Badiou S; Canaud B; Morena M
    J Nephrol; 2013; 26(3):556-63. PubMed ID: 22956433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients.
    Tsirpanlis G; Boufidou F; Manganas S; Chantzis K; Bleta A; Stamatelou K; Psimenou E; Nicolaou C
    Blood Purif; 2004; 22(6):518-24. PubMed ID: 15557765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.
    Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Filippi C; Mantuano E; Sidoti A; Grazi G; Antonelli A; Angelini D; Petrone I; Mura C; Tolaini P; Saloi F; Ghezzi PM; Barsotti G; Palla R
    Nephrol Dial Transplant; 2006 Mar; 21(3):756-62. PubMed ID: 16303780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
    Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
    Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin.
    Gustafsson S; Lind L; Söderberg S; Zilmer M; Hulthe J; Ingelsson E
    Obesity (Silver Spring); 2013 Jul; 21(7):1467-73. PubMed ID: 23585283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
    Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
    Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin E-Bonded Membranes Do Not Influence Markers of Oxidative Stress in Hemodialysis Patients with Homozygous Glutathione Transferase M1 Gene Deletion.
    Djuric P; Suvakov S; Simic T; Markovic D; Jerotic D; Jankovic A; Bulatovic A; Tosic Dragovic J; Damjanovic T; Marinkovic J; Naumovic R; Dimkovic N
    Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure.
    Sawires HK; Mohamed WA; Schaalan MF
    Iran J Kidney Dis; 2012 Sep; 6(5):366-72. PubMed ID: 22976263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients.
    As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B
    Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.